IUC26658-92 Efficacy Patterns of First-Line Immune Checkpoint Inhibitor Combinations in Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis Evaluating Ethnic Variations
Abstract Background First-line immune checkpoint inhibitor (ICI)-based combinations have transformed metastatic renal cell carcinoma (mRCC) outcomes. However, the influence of patient ethnicity remains poorly characterized due to historical underreporting in major clinical trials. This study performed an ethnicity-base...